Fig. (IMAGE) Osaka University Caption Giving medication a short half-life anti-IL-6 to patients of Sepsis, ARD, Burns, etc. is expected to suppress vascular damage or secondary infection. Credit Osaka University Usage Restrictions Credit must be given to the creator. License Original content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.